Toxicological Sciences 53, 213-223 (2000)
Copyright © 2000 by the Society of Toxicology
Responses of Transgenic Mouse Lines p53+/- and TgAC to Agents Tested in Conventional Carcinogenicity Bioassays



* National Institute of Environmental Health Sciences, Laboratory of Environmental Carcinogenesis and Mutagenesis, Research Triangle Park, North Carolina 27709; and
Integrated Laboratory Systems, Research Triangle Park, North Carolina 27709
The haplo-insufficient p53 knockout (p53+/-) and zetaglobin v-Ha-ras (TgAC) transgenic mouse models were compared to the conventional two rodent species carcinogen bioassay by prospectively testing nine chemicals. Seven of the chemicals classified as carcinogens in the conventional bioassay induced tumors in the liver or kidneys of B6C3F1 mice, and one (pentachlorophenol) also induced tumors in other tissues. Only three chemicals, furfuryl alcohol, pyridine, and pentachlorophenol, induced tumors in rats. The tumorigenic effect of pyridine was seen in F344 rats but not in Wistar strain rats. None of the chemicals induced tumors in the p53+/- transgenic mice, which is consistent with the absence of genotoxicity of these chemicals. Only two of the seven nongenotoxic carcinogens were positive in the TgAC model (lauric acid diethanolamine and pentachlorophenol). These results show that these transgenic models do not respond to many chemicals that show strain- or species-specific responses in conventional bioassays.
Key Words: TgAC, p53+/-; transgenic; mouse bioassays; cancer..
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. E. Kissling, D. E. Malarkey, M. K. Vallant, J. D. Johnson, M. R. Hejtmancik, R. A. Herbert, and G. A. Boorman Evaluation of Dichloroacetic Acid for Carcinogenicity in Genetically Modified Tg.AC Hemizygous and p53 Haploinsufficient Mice Toxicol. Sci., January 1, 2009; 107(1): 19 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.G. Allen, G. Pearse, J.K. Haseman, and R.R. Maronpot Prediction of Rodent Carcinogenesis: An Evaluation of Prechronic Liver Lesions as Forecasters of Liver Tumors in NTP Carcinogenicity Studies Toxicol Pathol, June 1, 2004; 32(4): 393 - 401. [Abstract] [PDF] |
||||
![]() |
T. Takizawa, K. Mitsumori, T. Tamura, M. Nasu, M. Ueda, T. Imai, and M. Hirose Hepatocellular Tumor Induction in Heterozygous p53-Deficient CBA Mice by a 26-Week Dietary Administration of Kojic Acid Toxicol. Sci., June 1, 2003; 73(2): 287 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Sistare, K. L. Thompson, R. Honchel, and J. DeGeorge Evaluation of the Tg.AC Transgenic Mouse Assay for Testing the Human Carcinogenic Potential of Pharmaceuticals--Practical Pointers, Mechanistic Clues, and New Questions International Journal of Toxicology, January 1, 2002; 21(1): 65 - 79. [Abstract] [PDF] |
||||
![]() |
K. R. Martin, C. Trempus, M. Saulnier, F. W. Kari, J.C. Barrett, and J. E. French Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice Carcinogenesis, September 1, 2001; 22(9): 1373 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. StJ. Battalora, J. W. Spalding, C. J. Szczesniak, J. E. Cape, R. J. Morris, C. S. Trempus, C. D. Bortner, B. M. Lee, and R. W. Tennant Age-dependent skin tumorigenesis and transgene expression in the Tg.AC (v-Ha-ras) transgenic mouse Carcinogenesis, April 1, 2001; 22(4): 651 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. French, R. D. Storer, and L. A. Donehower The Nature of the Heterozygous Trp53 Knockout Model for Identifi cation of Mutagenic Carcinogens Toxicol Pathol, January 1, 2001; 29(1_suppl): 24 - 29. [Abstract] [PDF] |
||||
![]() |
R. W. Tennant, S. Stasiewicz, W. C. Eastin, J. H. Mennear, and J. W. Spalding The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model Toxicol Pathol, January 1, 2001; 29(1_suppl): 51 - 59. [Abstract] [PDF] |
||||
![]() |
S. Venkatachalam, S. D. Tyner, C. R. Pickering, S. Boley, L. Recio, J. E. French, and L. A. Donehower Is p53 Haploinsufficient for Tumor Suppression? Implications for the p53+/- Mouse Model in Carcinogenicity Testing Toxicol Pathol, January 1, 2001; 29(1_suppl): 147 - 154. [Abstract] [PDF] |
||||
![]() |
P. L. Carmichael, J. J. Mills, M. Campbell, M. Basu, and J. Caldwell Mechanisms of Hormonal Carcinogenesis in the p53+/- Hemizygous Knockout Mouse: Studies With Diethylstilbestrol Toxicol Pathol, January 1, 2001; 29(1_suppl): 155 - 160. [Abstract] [PDF] |
||||
![]() |
J. I. Goodman A Perspective on Current and Future Uses of Alternative Models for Carcinogenicity Testing Toxicol Pathol, January 1, 2001; 29(1_suppl): 173 - 176. [Abstract] [PDF] |
||||
![]() |
J. Ashby Expectations for Transgenic Rodent Cancer Bioassay Models Toxicol Pathol, January 1, 2001; 29(1_suppl): 177 - 182. [Abstract] [PDF] |
||||



